| 000 | 00901 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515082442.0 | ||
| 264 | 0 | _c20080603 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1380-7870 | ||
| 024 | 7 |
_a10.1007/s10985-007-9049-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThall, Peter F | |
| 245 | 0 | 0 |
_aA review of phase 2-3 clinical trial designs. _h[electronic resource] |
| 260 |
_bLifetime data analysis _cMar 2008 |
||
| 300 |
_a37-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aClinical Trials, Phase II as Topic _xmethods |
| 650 | 0 | 4 |
_aClinical Trials, Phase III as Topic _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aResearch Design |
| 773 | 0 |
_tLifetime data analysis _gvol. 14 _gno. 1 _gp. 37-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10985-007-9049-x _zAvailable from publisher's website |
| 999 |
_c17293313 _d17293313 |
||